NO179232C - Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall - Google Patents

Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall

Info

Publication number
NO179232C
NO179232C NO893450A NO893450A NO179232C NO 179232 C NO179232 C NO 179232C NO 893450 A NO893450 A NO 893450A NO 893450 A NO893450 A NO 893450A NO 179232 C NO179232 C NO 179232C
Authority
NO
Norway
Prior art keywords
preparation
capsule
controlled release
active substances
ball device
Prior art date
Application number
NO893450A
Other languages
English (en)
Norwegian (no)
Other versions
NO893450L (no
NO179232B (no
NO893450D0 (no
Inventor
John Robert Cardinal
Scott Max Herbig
Richard Wilker Korsmeyer
Jeelin Lo
Kelly Lincoln Smith
Avinash Govind Thombre
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO893450D0 publication Critical patent/NO893450D0/no
Publication of NO893450L publication Critical patent/NO893450L/no
Publication of NO179232B publication Critical patent/NO179232B/no
Publication of NO179232C publication Critical patent/NO179232C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Executing Machine-Instructions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO893450A 1988-08-30 1989-08-29 Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall NO179232C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (4)

Publication Number Publication Date
NO893450D0 NO893450D0 (no) 1989-08-29
NO893450L NO893450L (no) 1990-03-01
NO179232B NO179232B (no) 1996-05-28
NO179232C true NO179232C (no) 1996-09-04

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893450A NO179232C (no) 1988-08-30 1989-08-29 Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall

Country Status (26)

Country Link
EP (1) EP0357369B1 (fr)
JP (1) JPH07112971B2 (fr)
KR (1) KR920008701B1 (fr)
CN (2) CN1058387C (fr)
AT (1) ATE89162T1 (fr)
AU (1) AU615104B2 (fr)
CA (1) CA1338552C (fr)
CZ (1) CZ277763B6 (fr)
DD (1) DD289466A5 (fr)
DE (1) DE68906488T2 (fr)
DK (1) DK175178B1 (fr)
EG (1) EG19189A (fr)
ES (1) ES2041006T3 (fr)
FI (1) FI102515B (fr)
HU (1) HU222245B1 (fr)
IE (1) IE62859B1 (fr)
IL (1) IL91398A (fr)
MX (1) MX173942B (fr)
MY (1) MY104183A (fr)
NO (1) NO179232C (fr)
NZ (1) NZ230470A (fr)
PL (1) PL163079B1 (fr)
PT (1) PT91560B (fr)
RU (2) RU1837873C (fr)
YU (1) YU47422B (fr)
ZA (1) ZA896586B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE69107461T2 (de) * 1990-08-07 1995-06-22 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
ATE106015T1 (de) * 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
TW235239B (fr) * 1992-11-20 1994-12-01 Pfizer
CA2150019C (fr) * 1992-11-30 1999-01-05 Scott M. Herbig Dispositifs de dispersion a membrane liquide
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (fr) 1996-05-29 1997-12-10 Pfizer Inc. Formulation d'une combinaison de cetirizine et pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
BR9810403A (pt) * 1997-07-01 2000-08-29 Pfizer Sais da sertralina e formas de dosagem de liberação sustentada da sertralina
SK173299A3 (en) * 1997-07-01 2000-11-07 Pfizer Prod Inc Delayed-release dosage forms of sertraline
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
NZ511614A (en) * 1998-11-12 2003-12-19 Smithkline Beecham P Modified release pharmaceutical composition containing the insulin sensitiser 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and the antidiabetic agent metaformin
WO2000069418A1 (fr) * 1999-05-17 2000-11-23 The Dow Chemical Company Procede de production de gelules d'ether de cellulose avec des acides organiques
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
KR20040098036A (ko) 2002-04-04 2004-11-18 화이자 프로덕츠 인크. 맛좋은 츄어블 정제
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
MX2007004741A (es) 2004-10-21 2007-09-07 Eurand Pharmaceuticals Ltd Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles.
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
KR20080030637A (ko) * 2005-06-29 2008-04-04 알자 코포레이션 삼투성 제형에 대하여 감소된 건조 시간을 제공하는반투과성 조성물
KR20120107533A (ko) 2005-11-28 2012-10-02 마리누스 파마슈티컬스 ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
EP2248541B1 (fr) * 2009-05-07 2018-10-31 Biotronik Ag Cathéter à ballonnet revêtu de médicament et son procédé de fabrication
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (fr) 2009-09-30 2011-04-07 Pfizer Inc. Formes pharmaceutiques orales à libération prolongée de latrépirdine
EP2506836B1 (fr) 2009-12-02 2018-02-14 Adare Pharmaceuticals S.R.L. Microcapsules de fexofénadine et compositions les contenant
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (fr) 2019-07-23 2021-01-28 Pfizer Inc. Formes posologiques à libération modifiée par voie orale
EP4057989A1 (fr) 2019-11-14 2022-09-21 Pfizer Inc. Combinaisons de 1-(((2s,3s,4s)-3-éthyl-4-fluoro-5-oxopyrrolidin-2-yl)méthoxy)-7-méthoxyisoquinoléine-6-carboxamide et formes pharmaceutiques orales
MX2022009557A (es) 2020-02-03 2022-11-14 Johnson & Johnson Consumer Inc Un comprimido masticable de una sola capa que comprende cetirizina.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (fr) * 1960-11-29
EP0056825B1 (fr) * 1981-01-22 1984-12-05 Capsugel A.G. Procédé pour la préparation de capsules pharmaceutiques ayant des propriétés entériques
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
EP0467488B1 (fr) * 1984-08-17 1995-10-11 The Wellcome Foundation Limited Composition à libération contrôlée d'une substance active
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
FI102515B1 (fi) 1998-12-31
EP0357369A3 (fr) 1991-10-02
FI102515B (fi) 1998-12-31
PT91560A (pt) 1990-03-30
RU1837873C (ru) 1993-08-30
NO893450L (no) 1990-03-01
HU222245B1 (hu) 2003-05-28
KR920008701B1 (ko) 1992-10-08
RU2093147C1 (ru) 1997-10-20
DK175178B1 (da) 2004-06-28
JPH02174713A (ja) 1990-07-06
FI894046A0 (fi) 1989-08-29
DE68906488D1 (de) 1993-06-17
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
EP0357369A2 (fr) 1990-03-07
PT91560B (pt) 1995-05-04
PL163079B1 (pl) 1994-02-28
MX173942B (es) 1994-04-11
IE892771L (en) 1990-02-28
ES2041006T3 (es) 1993-11-01
FI894046A (fi) 1990-03-01
DD289466A5 (de) 1991-05-02
HUT74086A (en) 1996-11-28
IE62859B1 (en) 1995-03-08
CN1042072A (zh) 1990-05-16
NZ230470A (en) 1991-06-25
ZA896586B (en) 1991-04-24
CN1125573A (zh) 1996-07-03
JPH07112971B2 (ja) 1995-12-06
CA1338552C (fr) 1996-08-27
DE68906488T2 (de) 1993-09-09
YU165789A (en) 1992-05-28
EG19189A (en) 1994-11-30
CZ277763B6 (en) 1993-04-14
IL91398A0 (en) 1990-04-29
AU615104B2 (en) 1991-09-19
MY104183A (en) 1994-02-28
NO179232B (no) 1996-05-28
YU47422B (sh) 1995-03-27
EP0357369B1 (fr) 1993-05-12
NO893450D0 (no) 1989-08-29
KR900002821A (ko) 1990-03-23
ATE89162T1 (de) 1993-05-15
CN1058387C (zh) 2000-11-15
IL91398A (en) 1994-05-30
AU4089189A (en) 1990-05-31
DK424489A (da) 1990-03-01

Similar Documents

Publication Publication Date Title
NO179232C (no) Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall
IE830572L (en) Osmotic drug delivery system
NO883837L (no) Anordning til avgivelse av et middel i et foerste tidsrom etterfulgt av et andre, lengre tidsrom.
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
NL168878C (nl) Werkwijze voor de bereiding van een stabiel, actieve zuurstof leverend, vloeibaar concentraat.
DK0489647T3 (da) N,O-sulfaterede heparosaner, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser.
DE3863749D1 (de) Wasserabsorptionsregulierte trocknungsvorrichtung.
ES2021579B3 (es) Capsulas divisibles en piezas
ES2022515B3 (es) Mezclas de sustancias granuladas para la preparacion de soluciones de dialisis. procedimiento para su preparacion. dispositivo para su realizacion.
GB1098006A (en) Sustained release pharmaceutical compositions
DE3854416D1 (de) Breitbandiger, sehr schneller Videoverstärker.
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
JPS51144733A (en) A remedy for hepatic failure
ES517977A0 (es) Procedimiento para la preparacion de una solucion que contiene glucosa y fructosa.
FI883738A (fi) Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekret haemmande medel.
JPS53124610A (en) Dialysate
JPS51131905A (en) Constant volume liquid diaphragm pump
JPS52125616A (en) Medical capsules
IT8224871A0 (it) Sistema per la somministrazione di medicamenti, programmabile e trapiantabile.
NO143469C (no) Patron som inneholder komponenter som innvirker paa hverandre i en selvherdende blanding, og fremgangsmaate til fremstilling av samme
ATE31313T1 (de) 13alpha-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate.